# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 31-40 of 671 results.
Testing Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 03, 2020
First Received: Feb 20, 2020
Disease(s): Acute Myeloid Leukemia
Intervention(s): Decitabine, Nivolumab, Venetoclax
Locations: Ohio State University Comprehensive Cancer Center LAO, Columbus, Ohio, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
Status: Not yet recruiting
Last Changed: Oct 09, 2019
First Received: Feb 18, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Decitabine, Venetoclax
Locations: University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2
Status: Not yet recruiting
Last Changed: Aug 28, 2019
First Received: Aug 28, 2019
Disease(s): Acute Myeloid Leukemia
Locations: European Institute of Oncology, Milano, Italy
Fondazione IRCCS Ca' Granda OSPEDALE MAGGIORE POLICLINICO, Milano, Italy
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Patients.
Status: Recruiting
Last Changed: Mar 13, 2020
First Received: Jul 14, 2017
Disease(s): Acute Myeloid Leukaemia
Intervention(s): AZD2811, Azacitidine, Venetoclax
Locations: Research Site, Denver, Colorado, United States
Research Site, Sarasota, Florida, United States
Research Site, Detroit, Michigan, United States
Research Site, Charlotte, North Carolina, United States
Research Site, Canton, Ohio, United States
... and 7 other locations.
Ex-vivo Expanded γδ T Lymphocytes in Patients With Refractory/Relapsed Acute Myeloid Leukaemia
Status: Recruiting
Last Changed: Aug 07, 2019
First Received: Jul 05, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Ex-vivo Expanded γδ T Lymphocytes
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Monotherapy in Patients With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia.
Status: Recruiting
Last Changed: Mar 24, 2020
First Received: Dec 20, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): Midostaurin
Locations: Novartis Investigative Site, Pleven, Bulgaria
Novartis Investigative Site, Sofia, Bulgaria
Novartis Investigative Site, Sofia, Bulgaria
Novartis Investigative Site, Varna, Bulgaria
Novartis Investigative Site, Zagreb, Croatia
... and 93 other locations.
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 16, 2020
First Received: Sep 10, 2014
Disease(s): Acute Myeloid Leukemia
Intervention(s): Gilteritinib, Idarubicin, Cytarabine, Daunorubicin
Locations: Site US10003, Los Angeles, California, United States
Site US10013, New Haven, Connecticut, United States
Site US10004, Chicago, Illinois, United States
Site US10009, Westwood, Kansas, United States
Site US10001, Baltimore, Maryland, United States
... and 7 other locations.
A Study of Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myeloid Leukemia
Status: Not yet recruiting
Last Changed: Jan 13, 2020
First Received: Sep 24, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Ficlatuzumab, Cytarabine
Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Oct 28, 2019
First Received: Jun 20, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): SKI-G-801
Locations: USC Norris Comprehensive Cancer Center, Clinical Investigations Support Office (CISO), 1441 Eastlake Ave., Rm. 7327, Los Angeles, California, United States
Innovative Clinical Research Institute, Whittier, California, United States
Dexamethasone Added to Intensive Chemotherapy in Older Patients With Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Oct 24, 2018
First Received: Aug 01, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Dexamethasone
Locations: CHU ANGERS - Maladies du sang, Angers, France
Ch Avignon, Avignon, France
CH de la Côte Basque - Hématologie, Bayonne, France
CHRU JEAN MINJOZ - Hématologie, Besançon, France
CHU Brest - Hôpital Morvan - Hématologie Clinique, Brest, France
... and 21 other locations.